BBS Antibodies

Santa Cruz Biotechnology features a diverse variety of BBS Antibodies for advanced research in cellular and molecular biology. BBS Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Bardet-Biedl syndrome (BBS) proteins are essential components in cilia function and cellular signaling pathways, influencing development, metabolism, and sensory perception. Research focused on Bardet-Biedl syndrome (BBS) proteins continues to reveal their significance in maintaining cellular homeostasis and proper organ function. Understanding Bardet-Biedl syndrome (BBS) proteins has led to significant discoveries about obesity, renal dysfunction, and retinal degeneration. Ongoing investigations of Bardet-Biedl syndrome (BBS) proteins help scientists uncover new therapeutic targets and potential treatment strategies. Current research utilizing Bardet-Biedl syndrome (BBS) proteins has expanded our knowledge of ciliopathies and their impact on human health. BBS monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding and potentially develop new therapeutic approaches for Bardet-Biedl syndrome and related conditions.